Daratumumab, Ixazomib, & Dexamethasone or Daratumumab, Bortezomib, & Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
Clinical trial NCT03942224 · UNKNOWN
Trial details
- NCT number
- NCT03942224
- Sponsor
- Emory University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-03
- Primary completion
- 2025-07-31
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.